SCHEMBL1542484

SCHEMBL1542484

CCOP(=O)(CCc1ccc([N+](=O)[O-])cc1)OCC

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.55
CA2 P00918 1/20 0.55
BCHE P06276 1/20 0.55
ACHE P22303 1/20 0.55
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPK1 P28482 1/20 0.50
HSD17B10 Q99714 1/20 0.50
AKR1C3 P42330 1/20 0.50
KCNH2 Q12809 7/20 0.47
KCNJ1 P48048 5/20 0.47
HRH3 Q9Y5N1 1/20 0.45
KDM4E B2RXH2 1/20 0.45
SIGMAR1 Q99720 1/20 0.44
IDO1 P14902 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78561 0.84 CA1 (0.58) CA1CA2BCHEACHETSHR
SCHEMBL8720914 0.80 AKR1C3 (0.60) CA1CA2BCHEACHETSHR
SCHEMBL17754402 0.78 PPARD (0.44) TSHRALDH1A1KCNH2HRH3KDM4E
SCHEMBL8093259 0.78 AKR1C3 (0.61) CA1CA2BCHEACHETSHR
SCHEMBL23703545 0.78 CA1 (0.51) CA1CA2BCHEACHETSHR
SCHEMBL7393069 0.77 GFER (0.45) TSHRCYP3A4SIGMAR1
SCHEMBL282093 0.77 PPARD (0.47) CA1CA2ACHETSHRALDH1A1
SCHEMBL1833048 0.77 TAAR1 (0.44) TSHRALDH1A1KDM4E
SCHEMBL10912425 0.77 TAAR1 (0.44) TSHRALDH1A1KDM4ESIGMAR1
SCHEMBL26486038 0.77 TAAR1 (0.44) TSHRSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499121-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS. F. Hoffmann-La Roche AG (CH) 2012-09-19 EP disclosed
WO-2011057973-A1 OXAZOLINE DERIVATIVES FOR TREATMENT OF CNS DISORDERS F. HOFFMANN-LA ROCHE AG (CH) 2011-05-19 WO disclosed
EP-2307372-A1 HETEROCYCLIC ANTIVIRAL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2011-04-13 EP disclosed